C
Coral Laboratories Ltd
BSE:524506
Coral Laboratories Ltd
BSE:524506
Price:
400
INR
-3.89%
Market Closed
Market Cap:
₹1.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Coral Laboratories Ltd
BSE:524506
|
IN |
|
Beijing Forever Technology Co Ltd
SZSE:300365
|
CN |
|
Posco Holdings Inc
NYSE:PKX
|
KR |
|
Antler Hill Mining Ltd
XTSX:AHM.H
|
CA |
|
Tai Ping Carpets International Ltd
HKEX:146
|
HK |
|
Fuji Corp (Miyagi)
TSE:7605
|
JP |
|
S
|
Simmonds Marshall Ltd
BSE:507998
|
IN |
|
G
|
Guangdong Hongjing Optoelectronic Technology Inc
SZSE:301479
|
CN |
|
I
|
Iron Mountain Inc
LSE:0JDP
|
US |
|
H
|
Hatsun Agro Product Ltd
BSE:531531
|
IN |
|
N
|
Nanogroup SA
WSE:NNG
|
PL |
|
Q
|
Quinenco SA
SGO:QUINENCO
|
CL |
|
Streamax Technology Co Ltd
SZSE:002970
|
CN |
Relative Value
The Relative Value of one CORALAB stock under the Base Case scenario is hidden INR. Compared to the current market price of 400 INR, Coral Laboratories Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CORALAB Relative Value
HIDDEN
Multiples Across Competitors
CORALAB Competitors Multiples
Coral Laboratories Ltd Competitors
Coral Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
C
|
Coral Laboratories Ltd
BSE:524506
|
1.4B INR | 1.6 | 10.2 | 3.6 | 4.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
